Position in A
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$1,251,657
+$311,095 QoQ
Shares Held
9,423
+14.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#465
of 1,112 holders
Holding Since
Jun 2024
9 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026CHOREO, LLC holds $21,207,266 across 19 Diagnostics & Research names. A ranks #4 (5.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
11,918 | $5,975,208 | |
| 2 | DHR |
Danaher Corp /De/
|
15,391 | $2,931,677 | |
| 3 | LH |
Labcorp Holdings Inc.
|
7,651 | $2,142,280 | |
| 4 | A |
Agilent Technologies, Inc.
This page
|
9,423 | $1,251,657 | |
| 5 | IDXX |
Idexx Laboratories Inc /De
|
2,125 | $1,118,685 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
5,581 | $1,078,360 | |
| 7 | ILMN |
Illumina, Inc.
|
5,103 | $897,260 | |
| 8 | NEO |
Neogenomics Inc
|
60,940 | $889,114 |
All Filings in A
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,251,657 | 9,423 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $940,562 | 8,252 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,217,282 | 8,946 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $1,079,038 | 8,407 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $839,523 | 7,114 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $812,426 | 6,945 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $1,156,533 | 8,609 | Shares | Sole | 2025-01-27 | |
| 2024-09-30 | $1,303,208 | 8,777 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $1,072,558 | 8,274 | Shares | Sole | 2024-08-07 | |
| No filing history on record for this holder in this stock. | ||||||